Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,144,839
  • Shares Outstanding, K 37,585
  • Annual Sales, $ 561,350 K
  • Annual Income, $ 58,270 K
  • 60-Month Beta 0.66
  • Price/Sales 2.00
  • Price/Cash Flow 7.35
  • Price/Book 0.66
Trade TARO with:

Options Overview Details

View History
  • Implied Volatility 34.23% ( -3.79%)
  • Historical Volatility 40.58%
  • IV Percentile 37%
  • IV Rank 51.14%
  • IV High 65.85% on 11/15/22
  • IV Low 1.14% on 12/09/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 13.00
  • Today's Open Interest 28
  • Open Int (30-Day) 33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.87
  • Number of Estimates 1
  • High Estimate 0.87
  • Low Estimate 0.87
  • Prior Year 0.70
  • Growth Rate Est. (year over year) +24.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.50 +10.76%
on 11/18/22
30.87 -1.33%
on 12/02/22
+1.56 (+5.40%)
since 11/02/22
3-Month
27.50 +10.76%
on 11/18/22
34.50 -11.71%
on 10/28/22
-2.04 (-6.28%)
since 09/02/22
52-Week
27.50 +10.76%
on 11/18/22
54.15 -43.75%
on 12/08/21
-21.48 (-41.36%)
since 12/02/21

Most Recent Stories

More News
Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates

Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TARO : 30.46 (+2.21%)
SCYX : 2.30 (+8.49%)
Taro: Fiscal Q2 Earnings Snapshot

Taro: Fiscal Q2 Earnings Snapshot

TARO : 30.46 (+2.21%)
Taro Provides Results for September 30, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2022.

TARO : 30.46 (+2.21%)
Taro to Release Second Quarter Results on October 27, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2022, after the close of market on Thursday, October...

TARO : 30.46 (+2.21%)
IsoRay (ISR) Reports Q4 Loss, Misses Revenue Estimates

IsoRay (ISR) delivered earnings and revenue surprises of 0% and 13.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ISR : 0.3856 (+1.00%)
TARO : 30.46 (+2.21%)
Galderma Delivers Strong H1 2022 Results and Continued Innovation Across Its Leading Dermatology Portfolio

Galderma:

TARO : 30.46 (+2.21%)
Taro Pharmaceutical (TARO) Lags Q1 Earnings Estimates

Taro (TARO) delivered earnings and revenue surprises of -56.47% and 4.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TARO : 30.46 (+2.21%)
IONS : 40.32 (+0.30%)
Taro Provides Results for the Quarter Ended June 30, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2022.

TARO : 30.46 (+2.21%)
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission (the...

TARO : 30.46 (+2.21%)
Taro to Release First Quarter Results on July 27, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June 30, 2022, after the close of market on Wednesday, July 27,...

TARO : 30.46 (+2.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals...

See More

Key Turning Points

3rd Resistance Point 32.50
2nd Resistance Point 31.69
1st Resistance Point 31.07
Last Price 30.46
1st Support Level 29.64
2nd Support Level 28.83
3rd Support Level 28.21

See More

52-Week High 54.15
Fibonacci 61.8% 43.97
Fibonacci 50% 40.83
Fibonacci 38.2% 37.68
Last Price 30.46
52-Week Low 27.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar